Skip to main content
Patient groups seek solutions to high drug prices

The National Multiple Sclerosis Society, the Leukemia and Lymphoma Society and the National Health Council are among the patient advocacy groups speaking out about prices that have put vital drugs out of many patients' reach. FasterCures has been facilitating conversations between payers and patient groups because "it's just another whole different series of competencies to have to master," says Managing Director Kim McCleary.

Full Story: